ITOS logo

iTeos Therapeutics (ITOS) Company Overview

Profile

Full Name:

iTeos Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

July 24, 2020

Indexes:

Not included

Description:

iTeos Therapeutics is a biotechnology company focused on developing innovative cancer treatments. They create new drugs that help the immune system fight cancer more effectively. Their research aims to improve patient outcomes and provide better options for those with difficult-to-treat cancers.

Key Details

Price

$6.98

Annual Revenue

$12.60 M(-95.29% YoY)

Annual EPS

-$3.15(-223.05% YoY)

Annual ROE

-18.19%

Beta

1.18

Events Calendar

Earnings

Next earnings date:

Mar 6, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 6, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 16, 25 HC Wainwright & Co.
Buy
Dec 19, 24 Wells Fargo
Overweight
Dec 13, 24 HC Wainwright & Co.
Buy
Nov 15, 24 HC Wainwright & Co.
Buy
Sep 16, 24 HC Wainwright & Co.
Buy
Aug 13, 24 Wells Fargo
Overweight
Aug 12, 24 JP Morgan
Overweight
May 13, 24 HC Wainwright & Co.
Buy
Mar 12, 24 JP Morgan
Overweight
Mar 7, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for iTeos Therapeutics?
  • Does iTeos Therapeutics pay dividends?
  • What sector is iTeos Therapeutics in?
  • What industry is iTeos Therapeutics in?
  • What country is iTeos Therapeutics based in?
  • When did iTeos Therapeutics go public?
  • Is iTeos Therapeutics in the S&P 500?
  • Is iTeos Therapeutics in the NASDAQ 100?
  • Is iTeos Therapeutics in the Dow Jones?
  • When was iTeos Therapeutics's last earnings report?
  • When does iTeos Therapeutics report earnings?
  • Should I buy iTeos Therapeutics stock now?

What is the ticker symbol for iTeos Therapeutics?

The ticker symbol for iTeos Therapeutics is NASDAQ:ITOS

Does iTeos Therapeutics pay dividends?

No, iTeos Therapeutics does not pay dividends

What sector is iTeos Therapeutics in?

iTeos Therapeutics is in the Healthcare sector

What industry is iTeos Therapeutics in?

iTeos Therapeutics is in the Biotechnology industry

What country is iTeos Therapeutics based in?

iTeos Therapeutics is headquartered in United States

When did iTeos Therapeutics go public?

iTeos Therapeutics's initial public offering (IPO) was on July 24, 2020

Is iTeos Therapeutics in the S&P 500?

No, iTeos Therapeutics is not included in the S&P 500 index

Is iTeos Therapeutics in the NASDAQ 100?

No, iTeos Therapeutics is not included in the NASDAQ 100 index

Is iTeos Therapeutics in the Dow Jones?

No, iTeos Therapeutics is not included in the Dow Jones index

When was iTeos Therapeutics's last earnings report?

iTeos Therapeutics's most recent earnings report was on Nov 12, 2024

When does iTeos Therapeutics report earnings?

The next expected earnings date for iTeos Therapeutics is Mar 6, 2025

Should I buy iTeos Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions